NL6715532A - - Google Patents

Info

Publication number
NL6715532A
NL6715532A NL6715532A NL6715532A NL6715532A NL 6715532 A NL6715532 A NL 6715532A NL 6715532 A NL6715532 A NL 6715532A NL 6715532 A NL6715532 A NL 6715532A NL 6715532 A NL6715532 A NL 6715532A
Authority
NL
Netherlands
Application number
NL6715532A
Other versions
NL157012B (en
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB51823/66A external-priority patent/GB1145884A/en
Priority claimed from GB5620366A external-priority patent/GB1206403A/en
Priority claimed from GB2626267A external-priority patent/GB1147626A/en
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Publication of NL6715532A publication Critical patent/NL6715532A/xx
Publication of NL157012B publication Critical patent/NL157012B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/02—Holding devices, e.g. on the body
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NL6715532.A 1966-11-18 1967-11-15 PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS WITH ANTI-INFLAMMATORY ACTION, PREPARED PRODUCTS SO OBTAINED, AND PROCESS FOR PREPARING ANTI-INFLAMMATORY EFFECTIVE HETEROCYCLICAL COMPOUNDS. NL157012B (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB51823/66A GB1145884A (en) 1966-11-18 1966-11-18 Thiazole derivatives
GB5620366A GB1206403A (en) 1966-12-15 1966-12-15 Oxazoles
GB2507667 1967-05-31
GB2626267A GB1147626A (en) 1966-07-15 1967-06-07 Thiazole derivatives
GB2738267 1967-06-14

Publications (2)

Publication Number Publication Date
NL6715532A true NL6715532A (en) 1968-05-20
NL157012B NL157012B (en) 1978-06-15

Family

ID=27516268

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6715532.A NL157012B (en) 1966-11-18 1967-11-15 PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS WITH ANTI-INFLAMMATORY ACTION, PREPARED PRODUCTS SO OBTAINED, AND PROCESS FOR PREPARING ANTI-INFLAMMATORY EFFECTIVE HETEROCYCLICAL COMPOUNDS.

Country Status (12)

Country Link
JP (1) JPS4938267B1 (en)
BE (1) BE706625A (en)
CH (9) CH545308A (en)
DE (2) DE1795822C2 (en)
ES (1) ES347319A1 (en)
FI (1) FI50416C (en)
FR (2) FR8018M (en)
IL (1) IL28803A (en)
LU (1) LU54891A1 (en)
NL (1) NL157012B (en)
PL (1) PL72562B1 (en)
SE (2) SE369307B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2096994A1 (en) * 1970-07-24 1972-03-03 Roussel Uclaf 2-para-cyclopropyl phenyl-4-(halo)phenyl-5-thiazolyl - alkanoic acids -antiinflammatory analgesic, antipyretic agents
US5643932A (en) * 1990-11-30 1997-07-01 Otsuka Pharmaceutical Co., Ltd. Superoxide radical inhibitor
US8354439B2 (en) 1996-09-30 2013-01-15 Otsuka Pharmaceutical Co., Ltd. Agent for inhibition of cytokine production and agent for inhibition of cell adhesion

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5113375U (en) * 1974-07-18 1976-01-30
JPS5182675A (en) * 1975-01-17 1976-07-20 Tokyo Shibaura Electric Co
GB1543154A (en) * 1975-05-02 1979-03-28 Lilly Industries Ltd Urea and carbamate derivatives
US4168315A (en) * 1977-09-28 1979-09-18 The Upjohn Company Dianisyl thiazole compound, compositions and method of antithrombotic treatment
US4697012A (en) * 1984-07-25 1987-09-29 Merck & Co., Inc. Morpholino pyridyl thiazole compound
IT1204751B (en) * 1986-01-03 1989-03-10 Therapicon Srl WATER SOLUBLE ACID DERIVATIVES 4,5 -DIPHENYL-2 -XSAZOLPROPIONIC, THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS
JPH10504542A (en) * 1994-07-27 1998-05-06 ジー．ディー．サール アンド カンパニー Substituted thiazole compounds for treating inflammation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130759C (en) * 1965-10-07

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2096994A1 (en) * 1970-07-24 1972-03-03 Roussel Uclaf 2-para-cyclopropyl phenyl-4-(halo)phenyl-5-thiazolyl - alkanoic acids -antiinflammatory analgesic, antipyretic agents
US5643932A (en) * 1990-11-30 1997-07-01 Otsuka Pharmaceutical Co., Ltd. Superoxide radical inhibitor
US5677319A (en) * 1990-11-30 1997-10-14 Otsuka Pharmaceutical Co., Ltd. Superoxide radical inhibitor
US6080764A (en) * 1990-11-30 2000-06-27 Otsuka Pharmaceutical Co., Ltd. Superoxide radical inhibitor
USRE37556E1 (en) 1990-11-30 2002-02-19 Otsuka Pharmaceutical Co., Ltd. Superoxide radical inhibitor
US8354439B2 (en) 1996-09-30 2013-01-15 Otsuka Pharmaceutical Co., Ltd. Agent for inhibition of cytokine production and agent for inhibition of cell adhesion

Also Published As

Publication number Publication date
FI50416B (en) 1975-12-01
CH556351A (en) 1974-11-29
IL28803A (en) 1974-05-16
CH560205A5 (en) 1975-03-27
DE1670005C2 (en) 1982-06-09
BE706625A (en) 1968-05-16
PL72562B1 (en) 1974-08-30
FR8018M (en) 1970-08-03
CH545308A (en) 1973-12-15
FI50416C (en) 1976-03-10
CH545309A (en) 1973-12-15
CH536311A (en) 1973-04-30
DE1670005A1 (en) 1970-08-06
SE369307B (en) 1974-08-19
SE422209B (en) 1982-02-22
NL157012B (en) 1978-06-15
LU54891A1 (en) 1968-02-08
DE1795822C2 (en) 1982-07-15
CH554884A (en) 1974-10-15
CH560203A5 (en) 1975-03-27
ES347319A1 (en) 1969-05-16
FR1584222A (en) 1969-12-19
CH528531A (en) 1972-09-30
JPS4938267B1 (en) 1974-10-16
CH545310A (en) 1973-12-15

Similar Documents

Publication Publication Date Title
AU5917865A (en)
AU428063B2 (en)
AU424443B2 (en)
AU414526B2 (en)
AU433222B2 (en)
AU421822B2 (en)
AU417216B2 (en)
AU415165B1 (en)
AU1144366A (en)
AU6703465A (en)
AU612166A (en)
AU5895065A (en)
AU1111066A (en)
AU218666A (en)
BE284991A (en)
BE597652A (en)
AU433620A (en)
AU415780B2 (en)
SE369307B (en)
AU407778B2 (en)
BE637138A (en)
BE662818A (en)
AU6852465A (en)
AU855865A (en)
AU92366A (en)

Legal Events

Date Code Title Description
NL80 Information provided on patent owner name for an already discontinued patent

Owner name: WYETH

V4 Discontinued because of reaching the maximum lifetime of a patent